Sponsored research agreement between Harvard and Roche resulted in the Kahne Lab’s discovery of the mechanism of action for Roche’s compound, paving the way for the development of new antibiotics.

Harvard University and Ono Pharmaceutical Co. (ONO) have launched a strategic alliance today to advance research across a broad range of therapeutic areas.

Researchers expand ways to improve the selectivity of catalytic reactions.

Harvard researchers have created an antibiotic that can overcome many drug-resistant infections.